Featured Video Play Icon
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • BioHarvest Sciences (BHSC) has announced that its dietary supplement, VINIA, has anti-aging properties via blood-flow improvement
  • As we age, our bodies produce more endothelin 1 and less nitric oxide, causing arteries and blood vessels to constrict and stiffen
  • VINIA reduces the endothelin 1 enzyme and increases nitric oxide molecules to increase artery dilation and improve blood flow
  • BioHarvest is the only industrial-scale plant cell technology company capable of producing active plant ingredients without growing the plant itself
  • BioHarvest Sciences (BHSC) is trading flat at $0.285 per share

BioHarvest Sciences (BHSC) has announced that its dietary supplement, VINIA, has anti-aging properties via blood-flow improvement.

As we age, our bodies produce more endothelin 1 (a vaso-constrictor) and less nitric oxide (a vaso-dilator), causing arteries and blood vessels to constrict and stiffen. This stiffening can reduce blood flow, reducing the supply of oxygen and nutrients carried to the body and its tissues.

VINIA reduces the endothelin 1 enzyme and increases nitric oxide molecules to increase artery dilation and improve blood flow.

Ilan Sobel, CEO of BioHarvest, commented,

“The composition of VINIA, with its Piceid Resveratrol from red grapes in addition to an entire matrix of powerful polyphenols, delivers superior results that translate into highly satisfied customers and a correspondingly high rate of customer retention.

Our superior product gives us significant differentiation and, as such, we expect to see the same level of enthusiasm for VINIA in the U.S. market as we have experienced in Israel since our launch of VINIA in that market in October 2020.”

To communicate VINIA’s benefits to the U.S. market, BioHarvest has contracted award-winning medical and scientific animator/illustrator, David Bolinsky, to create a series of animated videos.

The first video demonstrates the “double-action” effect by which VINIA increases artery dilation and reduces blood vessel constriction in the body.

The company will release two additional videos over the next few weeks showcasing VINIA’s advantage from a solubility and bioavailability perspective.​

BioHarvest Sciences is the only industrial-scale plant cell technology company capable of producing active plant ingredients without growing the plant itself. 

BioHarvest Sciences (BHSC) is trading flat at $0.285 per share as of 11:38 am ET.

More From The Market Herald

" Micromem Technologies (CSE:MRM) closes private placement

Micromem Technologies (MRM) has closed a private placement for gross proceeds of $282,000.
PyroGenesis - Vice President of Sales, Massimo Dattilo.

" PyroGenesis (TSX:PYR) completes titanium powder order from Aubert & Duval

PyroGenesis (PYR) has completed a 100 kg titanium powder order from Aubert & Duval.

" Adamant Global Holdings (CSE:ADMT) releases 2021 results

Adamant (ADMT) has released its 2021 financial results headlined by significant revenue growth.

" Buzz on the Bullboards: The Larger the Hubs, the Heavier the Debates

Several of Stockhouse’s larger Bullboard hubs have set off serious debates on the future direction of some companies following significant moves this past